< Back to previous page
Researcher
Anne-Theres Henze
- Disciplines:Morphological sciences, Oncology
Affiliations
- Laboratory of Tumor Inflammation and Angiogenesis (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → 5 Feb 2017
Projects
1 - 2 of 2
- Mir-210 at the crossroad of M2 and M1 macrophage polarization: relevance for sepsis and cancer.From1 Jan 2015 → 31 Dec 2017Funding: FWO research grant KAN
- The role of PHD mediated suppression of NF-kB signaling in tumor inflammation.From1 Oct 2011 → 5 Feb 2017Funding: FWO fellowships
Publications
1 - 5 of 5
- The impact of hypoxia on tumor-associated macrophages(2016)
Authors: Anne-Theres Henze, Max Mazzone
Pages: 3672 - 3679 - Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival(2015)
Authors: Anne-Theres Henze, Max Mazzone
Pages: 2814 - 27 - Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR(2014)
Authors: Anne-Theres Henze, Peter Carmeliet
- PHD2 regulates arteriogenic macrophages through TIE2 signalling(2013)
Authors: Alexander Hamm, Anne-Theres Henze, Mathias Wenes, Max Mazzone
Pages: 843 - 57 - Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity(2012)
Authors: Sofie Deschoemaeker, Anne-Theres Henze, Koen Debackere, Veronica Finisguerra, Lorenzo Veschini, Myriam Baes, Jan D'hooge, Peter Carmeliet, Max Mazzone
Pages: 263 - 277
Patents
1 - 3 of 3